Hydromorphone for Perioperative Analgesia in Lung Tumor Ablation Parallel Controlled
Status:
Not yet recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
This randomized, parallel controlled, single blind trial is designed to evaluate the efficacy
and safety of hydromorphone versus morphine for perioperative analgesia in lung tumor
ablation.